Randomized, Placebo-Controlled, Phase IIB Evaluation of Cyclooxygenase-2 Activity in Surgically Resected Primary Colorectal Adenomas and Carcinomas After 7 Days Pretreatment With Celecoxib
Interventional
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Martin J Heslin, M.D.
Principal Investigator
University of Alabama at Birmingham
United States: Institutional Review Board
F001228004
NCT00582660
December 2001
June 2008
Name | Location |
---|---|
University of Alabama at Birmingham | Birmingham, Alabama 35294-3300 |